Beyond targeting the primary tumor region, a very recent study demonstrated the potential of iodine-124 labeled anti-PD-L1 fragments to offer good tumor-to-background contrast for visualizing metastases, with minimal radionuclide shedding to bone and tumor-to-liver ratios of 2 in non-small cell lung cancer (17). This evidence concerns the gene CD274 and neoplasm.